Background Image
Menu

Latest News

GM&C Life Sciences Fund Invests in SwabTech

29 September 2016

GM&C Life Sciences Fund Invests in SwabTech

Alderley Park, Cheshire, UK – 29 September 2016. Catapult Ventures, managers of the GM&C Life Sciences Fund, today announced an £0.5m investment in Manchester-based SwabTech Limited to further develop and commercialise its automated Surgical Swab-Washer...

Catapult Ventures Seed Investments

28 September 2016

Catapult Ventures Seed Investments

GM&C Life Sciences Fund makes further seed investments

22 September 2016

GM&C Life Sciences Fund makes further seed investments

Alderley Park, Cheshire, UK – 20 September 2016. Catapult Ventures, managers of the GM&C Life Sciences Fund, has announced that it has completed two new seed investments. The Fund completed a seed investment into sensor technology developer Kanichi Research in August...

Intamac in software deal with Sprue Aegis

20 September 2016

Intamac in software deal with Sprue Aegis

Northampton-based software firm Intamac has sold the source code and development rights to a piece of its software to Coventry-based Sprue Aegis in a deal that could be worth up to £2.8m. Some £1m will be paid by Sprue initially, together with £0.45m pre-paid...

New Board Member joins Monica

8 September 2016

New Board Member joins Monica

Wolfgang Distler joins the Monica Board of Directors, bringing with him a wealth of commercial experience in the medical and other industries. Wolfgang was the founder of Reynolds Medical in Germany in 1978, and from 1991 until 2003 he was Managing Director of Reynolds Medical...

Catapult Ventures appoints Dr Tony Flinn as Venture Partner

16 August 2016

Catapult Ventures appoints Dr Tony Flinn as Venture Partner

Catapult Ventures has announced that Dr Tony Flinn has been appointed as a Venture Partner with its new GM&C Life Sciences Fund. Dr Flinn, who becomes the Fund’s second Venture Partner, is an authority in contract research organisation (CRO) companies, having founded...

Faron enters into an agreement with Abzena for the manufacture of Clevegen®

10 August 2016

Faron enters into an agreement with Abzena for the manufacture of Clevegen®

Turku, Finland and Cambridge, UK – 25 July 2016 – Faron Pharmaceuticals Ltd (AIM: FARN) (“Faron”), a clinical stage biopharmaceutical company, and Abzena plc (AIM: ABZA), a life sciences group providing services and technologies to enable development and...

Monica Healthcare is a winner in the 2016 Premier Inc Innovation Celebrations

30 June 2016

Monica Healthcare is a winner in the 2016 Premier Inc Innovation Celebrations

GE Healthcare on behalf of Monica Healthcare showcased the Monica Novii Wireless Patch System at Premier Inc.’s 2016 annual Breakthroughs Conference. Monica’s Novii System is one of the medical innovations that was showcased in front of thousands of healthcare...

Catapult Ventures appoints Dr David Whitcombe as Venture Partner

9 June 2016

Catapult Ventures appoints Dr David Whitcombe as Venture Partner

Catapult Ventures has announced that Dr David Whitcombe has become a Venture Partner with its new GM&C Life Sciences Fund. Dr Whitcombe, who has worked alongside Catapult and its portfolio companies for a number of years informally, is best known as a co-founder of DxS...

Probe Scientific in top disruptive medical technologies index

8 June 2016

Probe Scientific in top disruptive medical technologies index

British early stage medical device and diagnostic company, Probe Scientific Ltd has been named one of the world’s most influential companies on the Disrupt 100 index which lists “companies shaping our futures”. The largest sector for disruption is Health Tech...